News Headlines Article

‘The people that most need this drug can’t afford it’: HIV advocates target Gilead meeting, but company says they’re wrong
San Francisco Business Times

In shout-down with Gilead management, groups say company’s patent for Truvada — the only drug approved for preventing new HIV infections — should be stripped.